Indaptus Therapeutics, Inc.
INDP· Nasdaq
10-K due Mar 10 – 24
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 5 filings.
Up after 3 of 12, down after 9.
Indaptus Therapeutics, Inc. · CIK 1857044 · Engraved from SEC EDGAR
Based on 5 prior 10-K filings.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −9.9% after Q1 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.